0.3464
price up icon4.75%   0.0157
after-market After Hours: .35 0.0036 +1.04%
loading

Athira Pharma Inc Stock (ATHA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Research and Development
10.32%
21.24
23.68 27.20 21.61 21.29
Costs And Expenses
4.57%
27.69
29.01 35.04 31.64 29.77
Operating Income/Loss
4.57%
-27.69
-29.01 -35.04 -31.64 -29.77
Income/Loss From Continuing Operations Before Tax
3.47%
-26.34
-27.29 -35.04 -29.60 -27.82
Income/Loss From Continuing Operations After Tax
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Net Income/Loss
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Diluted Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Basic Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Diluted Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):